Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry
Clemens Kamrath, Joachim Rosenbauer, Alexander J. Eckert, et al.
Diabetes Care (2022) Vol. 45, Iss. 8, pp. 1762-1771
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents
Ingrid Libman, Aveni Haynes, Sarah K. Lyons, et al.
Pediatric Diabetes (2022) Vol. 23, Iss. 8, pp. 1160-1174
Open Access | Times Cited: 131
Diabetes and the COVID-19 pandemic
Kamlesh Khunti, Jonathan Valabhji, Shivani Misra
Diabetologia (2022) Vol. 66, Iss. 2, pp. 255-266
Open Access | Times Cited: 75
Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic
D.M. D'Souza, Jessica Empringham, Petros Pechlivanoglou, et al.
JAMA Network Open (2023) Vol. 6, Iss. 6, pp. e2321281-e2321281
Open Access | Times Cited: 65
The immunology of type 1 diabetes
Kevan C. Herold, Thomas Delong, Ana Luisa Perdigoto, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 6, pp. 435-451
Open Access | Times Cited: 41
Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries
Niels H. Birkebæk, Clemens Kamrath, Julia M. Grimsmann, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 11, pp. 786-794
Open Access | Times Cited: 65
The bidirectional association between diabetes and long-COVID-19 – A systematic review
Jessica L. Harding, Sofia Oviedo, Mohammed K. Ali, et al.
Diabetes Research and Clinical Practice (2022) Vol. 195, pp. 110202-110202
Open Access | Times Cited: 62
COVID-19 and children
Carl A. Pierce, Kevan C. Herold, Betsy C. Herold, et al.
Science (2022) Vol. 377, Iss. 6611, pp. 1144-1149
Open Access | Times Cited: 57
Limited extent and consequences of pancreatic SARS-CoV-2 infection
Verena van der Heide, Sonia Jangra, Phillip Cohen, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110508-110508
Open Access | Times Cited: 48
SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study
Mikael Knip, Anna Parviainen, Maaret Turtinen, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 4, pp. 251-260
Open Access | Times Cited: 30
COVID-19 as a Trigger for Type 1 Diabetes
Yichen Wang, Hui Guo, Gongquan Wang, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 9, pp. 2176-2183
Closed Access | Times Cited: 29
Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19
Andreas Weiß, Ewan Donnachie, Andreas Beyerlein, et al.
JAMA (2023) Vol. 329, Iss. 23, pp. 2089-2089
Open Access | Times Cited: 29
New‐onset type 1 diabetes in children and adolescents as postacute sequelae of SARS‐CoV‐2 infection: A systematic review and meta‐analysis of cohort studies
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 27
New-Onset Diabetes After COVID-19
Sun H. Kim, Ipsa Arora, Daniel S. Hsia, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. e1164-e1174
Closed Access | Times Cited: 25
Incidence and presentation of new-onset type 1 diabetes in children and adolescents from Germany during the COVID-19 pandemic 2020 and 2021: Current data from the DPV Registry
Christina Baechle, Alexander J. Eckert, Clemens Kamrath, et al.
Diabetes Research and Clinical Practice (2023) Vol. 197, pp. 110559-110559
Closed Access | Times Cited: 22
Risk of Type 1 Diabetes in Children Is Not Increased After SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark
Rohina Noorzae, Thor Grønborg Junker, Anders Hviid, et al.
Diabetes Care (2023) Vol. 46, Iss. 6, pp. 1261-1264
Open Access | Times Cited: 22
SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany
Marian Rewers, Ezio Bonifacio, Dominik Ewald, et al.
JAMA (2022) Vol. 328, Iss. 12, pp. 1252-1252
Open Access | Times Cited: 28
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
Marija Lugar, Anne Eugster, Peter Achenbach, et al.
JAMA (2023) Vol. 330, Iss. 12, pp. 1151-1151
Open Access | Times Cited: 19
Pregnancy complications in women with pregestational and gestational diabetes mellitus
Lukas Reitzle, Christin Heidemann, Jens Baumert, et al.
Deutsches Ärzteblatt international (2023)
Open Access | Times Cited: 16
Association of COVID-19 and Development of Type 1 Diabetes: A Danish Nationwide Register Study
Bochra Zareini, Kathrine Kold Sørensen, Pia Eiken, et al.
Diabetes Care (2023) Vol. 46, Iss. 8, pp. 1477-1482
Open Access | Times Cited: 16
The countdown to type 1 diabetes: when, how and why does the clock start?
Anette‐Gabriele Ziegler
Diabetologia (2023) Vol. 66, Iss. 7, pp. 1169-1178
Open Access | Times Cited: 15
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 588-599
Closed Access | Times Cited: 5
Hospital-Based Analysis of Early-Onset Diabetes in Ghana's Upper East Region: Prevalence, Complications, and Challenges
B. A. Solomon, Ceasar Kaba, Joy Afua Mensah, et al.
(2025)
Closed Access
Anti-viral action against Type 1 diabetes autoimmunity: the GPPAD-AVAnT1A study protocol
Sandra Hummel, Alexandra Käßl, Stefanie Arnolds, et al.
Contemporary Clinical Trials Communications (2025) Vol. 44, pp. 101434-101434
Open Access
Examination of Trends in Diabetes Incidence Among Children During the COVID-19 Pandemic in Ontario, Canada, From March 2020 to September 2021
Rayzel Shulman, Eyal Cohen, Thérèse A. Stukel, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2223394-e2223394
Open Access | Times Cited: 25
Incidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: A systematic review with meta‐analysis
Ignacio Hormazábal‐Aguayo, Yasmín Ezzatvar, Nidia Huerta‐Uribe, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 40, Iss. 3
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top